Getinge (GETI B.ST) Hisse Fiyat
Getinge Fiyat
Gelir, son 19 yılda yıllık bileşik %5,3 artarak 34,97 Md SEK seviyesine ulaştı. Hisse başına kâr, son 19 yılda yıllık %3,1 büyüdü. Getinge şirketinde net marj %6,5 seviyesinde bulunuyor; birkaç yıl önceki %11,0 seviyesine göre geriledi. Getinge şu anda yaklaşık %1,82 temettü verimi sunuyor. Temettü dağıtım oranı, kârın yaklaşık %55 düzeyindedir. Temettü, son 19 yılda yıllık %4,7 artış gösterdi. Analistler 231,03 SEK medyan fiyat hedefi belirliyor; bu, güncel fiyatın %8,8 altında bir seviyeye işaret ediyor. 14 analistten 8 tanesi hisse için alım öneriyor — genel konsensüs: Al.
Getinge hisse senedi fiyatı
Getinge iş modeli ve hisse analizi
Getinge hakkında sık sorulan sorular
Getinge AB is a global medical technology company that specializes in providing solutions for hospitals and healthcare organizations. The business model of Getinge AB revolves around offering innovative products, systems, and services within areas such as surgical workflows, patient care, and infection control. They strive to improve patient outcomes and enable healthcare professionals to deliver efficient and safe care. With a focus on providing high-quality medical equipment and integrated solutions, Getinge AB aims to enhance the overall healthcare experience.
Getinge AB is primarily active in the healthcare industry.
The main competitors of Getinge AB in the market include leading medical technology companies such as Medtronic, Johnson & Johnson, and Siemens Healthineers. These companies also provide a wide range of innovative medical devices and solutions, competing with Getinge AB in areas such as surgical equipment, patient handling systems, and infection control products. Getinge AB, as a global provider of medical technology, faces intense competition in its quest to deliver advanced healthcare solutions to customers worldwide.
Getinge AB, a renowned Swedish company, has a rich history and a strong background in the healthcare industry. Established in 1904, Getinge has evolved into a global leader in medical technology, providing innovative solutions for infection control and surgical workflows. With a primary focus on improving patient outcomes and enhancing healthcare efficiency, Getinge offers a wide range of products and services, including advanced medical equipment, such as surgical tables, anesthesia systems, and sterilization equipment. Over the years, Getinge has expanded its operations internationally, becoming a trusted partner for healthcare institutions worldwide. Through continuous innovation and dedication to healthcare excellence, Getinge AB has firmly established itself as a leading player in the global medical technology market.
Getinge AB has achieved several significant milestones throughout its history. One major accomplishment was the acquisition of Maquet in 2000, which expanded the company's portfolio and global reach. In 2006, Getinge AB successfully listed its shares on the Stockholm Stock Exchange, strengthening its position in the market. The company has also made substantial progress in research and development, introducing innovative medical technology solutions for healthcare professionals worldwide. Additionally, Getinge AB has focused on sustainability initiatives, committing to reducing its carbon footprint and promoting environmentally friendly practices. These milestones demonstrate Getinge AB's commitment to growth, innovation, and sustainability in the healthcare industry.
Getinge AB, a renowned global medical technology company based in Sweden, operates in multiple countries and regions worldwide. With a strong international presence, Getinge AB extends its operations across various continents, including Europe, Asia, North America, and Latin America. The company establishes its footprint in countries such as Sweden, Germany, France, the United States, China, Brazil, and many more. Through its extensive network and subsidiaries, Getinge AB serves customers across the globe, contributing to the advancement of healthcare and improving patient outcomes.
Getinge AB is committed to upholding certain values and corporate philosophy. The company believes in promoting patient safety and enhancing healthcare outcomes. They prioritize quality in their products and services, ensuring efficient and reliable medical solutions. Getinge AB strives for sustainability by minimizing the environmental impact of their operations and products. They value transparency, integrity, and accountability in their business practices. Getinge AB consistently focuses on innovation and advancement in the healthcare industry, aiming to improve patients' lives worldwide. With their dedication to their mission and values, Getinge AB continues to be a trusted and influential player in the medical technology sector.
Analistler şu anda Getinge hissesi için ortalama 238,81 SEK hedef fiyat belirliyor (medyan: 231,03 SEK); bu, son fiyata göre -5,7 % anlamına gelir. Konsensüs 14 analist notuna dayanır.
14 analist şu anda Getinge hissesini değerlendiriyor: 8 al, 5 tut, 1 sat öneriyor. 2026 için analistler Getinge şirketinin 35,26 Md SEK gelir ve 12,89 SEK hisse başına kâr üretmesini bekliyor.
Güncel döviz kuruyla Getinge hissesi 22,62 EUR (253,20 SEK) seviyesindedir.
Getinge hissesi (GETI B.ST) 9 borsada işlem görür, bunlar arasında: London (0GZV.L), SIX (Zürich) (GETIB.SW), Frankfurt (GTN.F), München (GTN.MU), Düsseldorf (GTN.DU), Stockholm (GETI B.ST).
Getinge AB is a Swedish company specializing in the manufacturing of medical devices and solutions. The company operates in three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers products and services to improve patient care and enhance the efficiency and profitability of hospitals and medical facilities. They provide solutions for critical care situations, infection prevention and control, as well as for the life sciences, pharmaceutical, and food industries. Getinge also offers products and solutions for surgical workflows, including cleaning, disinfection, sterilization, and training services. The company follows a value-based healthcare model, aiming to provide value to customers by ensuring optimal patient treatment and economic responsibility. With a focus on continuous innovation, Getinge strives to meet the evolving needs of its customers as a global leader in the medical technology industry.
beklenen'nin Getinge hasılatı 35,26 Md SEK'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
beklenen'nin Getinge karı 3,51 Md SEK'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Getinge'nin Fiyat/Kazanç (F/K) oranı şu anda 19,65'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Getinge hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Getinge'nin Fiyat/Satış (F/S) oranı şu anda 1,96'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Getinge hisse senedinin değerleme metriği olarak hizmet eder.
Getinge'nin Eulerpool Kalite Puanı 4/10'dur.
Getinge'nin ISIN'i SE0000202624'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Getinge'nin WKN'i 889714'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
Getinge'nin ticker'ı GETI B.ST'dir. Ticker sembolü, Getinge hisseleri borsada işlem görmek için kullanılır.
Getinge Hissesi
Getinge Emsaller Grubu
Getinge Ticker
Getinge FIGI
Getinge'nin tüm temel göstergeleri ve derinlemesine analizi
Getinge hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Getinge şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: